1 – 10 of 67
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Diagnosis and management of severe congenital protein C deficiency (SCPCD) : Communication from the SSC of the ISTH
(
- Contribution to journal › Article
- 2021
-
Mark
Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
Extracellular vesicles in renal inflammatory and infectious diseases
(
- Contribution to journal › Scientific review
-
Mark
Thrombotic Risk Determined by STAB 2 Variants in a Population-Based Cohort Study
(
- Contribution to journal › Letter
- 2020
-
Mark
Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction : A Prespecified Subgroup Analysis of the VALIDATE-SWEDEHEART Trial
(
- Contribution to journal › Article
-
Mark
Infections Related to the Use of Medical Devices and Changes in the Oropharyngeal Flora
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2019
-
Mark
Assessing the Nationwide Impact of a Registry-Based Randomized Clinical Trial on Cardiovascular Practice
(
- Contribution to journal › Article
-
Mark
Exosomes and microvesicles in normal physiology, pathophysiology, and renal diseases
(
- Contribution to journal › Scientific review
-
Mark
Cangrelor for ST-Segment-Elevation Myocardial Infarction
(
- Contribution to journal › Debate/Note/Editorial
- 2018
-
Mark
No benefit of ticagrelor pretreatment compared with treatment during percutaneous coronary intervention in patients with ST-segment⇓elevation myocardial infarction undergoing primary percutaneous coronary intervention
(
- Contribution to journal › Article